Filing Details
- Accession Number:
- 0001127602-25-006042
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-20 17:18:37
- Reporting Period:
- 2025-02-18
- Filing Date:
- 2025-02-20
- Accepted Time:
- 2025-02-20 17:18:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1520262 | Alkermes Plc. | ALKS | Pharmaceutical Preparations (2834) | 981007018 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
2010945 | Joseph Samuel Parisi | 900 Winter Street Waltham MA 02451 | Vp, Finance (Interim Pao) | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2025-02-18 | 2,033 | $0.00 | 9,750 | No | 4 | M | Direct | |
Ordinary Shares | Disposition | 2025-02-18 | 706 | $35.90 | 9,044 | No | 4 | F | Direct | |
Ordinary Shares | Disposition | 2025-02-20 | 1,327 | $35.69 | 7,717 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares | Restricted Stock Unit Award | Disposition | 2025-02-18 | 2,033 | $0.00 | 2,033 | $0.00 |
Ordinary Shares | Employee Stock Option (Right to Buy) | Acquisiton | 2025-02-19 | 12,287 | $0.00 | 12,287 | $35.84 |
Ordinary Shares | Restricted Stock Unit Award | Acquisiton | 2025-02-19 | 11,965 | $0.00 | 11,965 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
2,034 | No | 4 | M | Direct | ||
12,287 | 2035-02-19 | No | 4 | A | Direct | |
11,965 | No | 4 | A | Direct |
Footnotes
- Each restricted stock unit represents a contingent right to receive one ordinary share.
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 9/11/2024.
- Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/18/2023.
- Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/19/2026.
- Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/19/2026.